Pembrolizumab (metastatic breast cancer): Solution concentrate for I.V. infusion 100 mg in 4 mL vial; Keytruda® Page last updated: 30 June 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.3MB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 1.2MB)